(Reuters) - The diagnostics company said in a statement its board
determined that the $75 per share offer is "inadequate in
multiple respects and contrary to the best interests of
Ventana's stockholders."
Already one of the world's largest diagnostic companies,
Roche announced late last month it would launch a hostile offer
for Ventana. The deal represented a 45 percent premium to
Ventana shares at the time.
Read more at Reuters.com Mergers News
determined that the $75 per share offer is "inadequate in
multiple respects and contrary to the best interests of
Ventana's stockholders."
Already one of the world's largest diagnostic companies,
Roche announced late last month it would launch a hostile offer
for Ventana. The deal represented a 45 percent premium to
Ventana shares at the time.
Read more at Reuters.com Mergers News
No comments:
Post a Comment